Tag: Lumbosacral Radicular Pain Management Market Size

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Lumbosacral Radicular Pain Market Size, Value And Growth Trajectory Through 2030

The lumbosacral radicular pain market has witnessed strong expansion in recent years. It is projected to increase from $0.97 billion in 2025 to $1.02 billion in 2026, registering a compound annual growth rate (CAGR) of 6.0%. The historical growth of this market can be linked to elements like an aging population, the prevalence of spinal degenerative disorders, the approach of opioid-based pain management, the establishment of hospital pain clinics, and the rising volumes of orthopedic surgeries.

The lumbosacral radicular pain market size is anticipated to undergo significant growth in the upcoming years. It is projected to achieve a value of $1.28 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.7%. This expansion during the forecast period can be ascribed to elements such as the embrace of non-opioid pain therapy, the increase in outpatient pain procedures, the emergence of digital pain monitoring tools, advancements in minimally invasive spine technologies, and the broadening of rehabilitation programs. Prominent trends within the forecast timeframe encompass the rising utilization of multimodal pain management, the expansion of interventional spine procedures, an elevated demand for non-opioid therapies, the growth of rehabilitation-based care, and the adoption of minimally invasive pain treatments.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=12795152&type=smp&name=Lumbosacral%20Radicular%20Pain%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Lumbosacral Radicular Pain Market Growth Momentum: What Factors Are Shaping Demand?

The growing occurrence of degenerative spinal conditions is anticipated to drive expansion in the lumbosacral radicular pain market. These conditions encompass various disorders resulting from the progressive deterioration of the spine over time. The increase in degenerative spinal conditions stems from an aging global population and lifestyle choices that heighten the likelihood of spinal degradation and nerve compression, consequently boosting the need for diagnostic and therapeutic interventions. Lumbosacral radicular pain serves as an indicator of underlying degenerative spinal issues by signaling irritation or compression of nerve roots, thereby guiding clinical assessments and treatment strategies. For example, the University of Sydney, an Australian public university, reported in May 2023 an expectation that over 800 million individuals globally will experience back discomfort by the year 2050. This surge in degenerative spinal conditions is, therefore, a key factor propelling the growth of the lumbosacral radicular pain market.

Lumbosacral Radicular Pain Market Segmentation And Category Overview

The lumbosacral radicular pain market covered in this report is segmented –

1) By Treatment Type: Pharmacological Treatment, Non-Pharmacological Treatment, Interventional Procedures

2) By Route Of Administration: Oral, Topical, Injectable, Implantable

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By End User: Hospitals, Specialty Clinics, Rehabilitation Centers, Homecare Settings

Subsegments:

1) By Pharmacological Treatment: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Anticonvulsants, Antidepressants, Muscle Relaxants, Corticosteroids

2) By Non-Pharmacological Treatment: Physical Therapy, Exercise And Rehabilitation Programs, Chiropractic Care, Acupuncture, Cognitive Behavioral Therapy, Heat And Cold Therapy

3) By Interventional Procedures: Epidural Steroid Injections, Radiofrequency Ablation, Nerve Root Blocks, Spinal Cord Stimulation, Minimally Invasive Decompression, Intrathecal Drug Delivery Systems

Lumbosacral Radicular Pain Market Competitive Analysis Of Leading Industry Participants

Major companies operating in the lumbosacral radicular pain market are Medtronic plc, Boston Scientific Corporation, Nevro Corp., SPR Therapeutics, Saluda Medical Pty Ltd., Nalu Medical Inc., Abbott Neuromodulation, Stryker Corporation, Zimmer Biomet Holdings Inc., Globus Medical Inc., NuVasive Inc., Orthofix Medical Inc., B. Braun Melsungen AG, Teleflex Incorporated, Merit Medical Systems Inc., Avanos Medical Inc., Halyard Health Inc., Terumo Corporation, Baxter International Inc., Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Pfizer CentreOne, Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Lupin Limited, Zydus Lifesciences Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals Inc., Perrigo Company plc

View The Full Lumbosacral Radicular Pain Market Report:

https://thebusinessresearchcompany.com/report/lumbosacral-radicular-pain-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Lumbosacral Radicular Pain Market Geographic Landscape: Which Region Leads Industry Growth?

North America was the largest region in the lumbosacral radicular pain market in 2025. The regions covered in the lumbosacral radicular pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Lumbosacral Radicular Pain Market Size, Value And Growth Trajectory Through 2030

The lumbosacral radicular pain market has witnessed strong expansion in recent years. It is projected to increase from $0.97 billion in 2025 to $1.02 billion in 2026, registering a compound annual growth rate (CAGR) of 6.0%. The historical growth of this market can be linked to elements like an aging population, the prevalence of spinal degenerative disorders, the approach of opioid-based pain management, the establishment of hospital pain clinics, and the rising volumes of orthopedic surgeries.

The lumbosacral radicular pain market size is anticipated to undergo significant growth in the upcoming years. It is projected to achieve a value of $1.28 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.7%. This expansion during the forecast period can be ascribed to elements such as the embrace of non-opioid pain therapy, the increase in outpatient pain procedures, the emergence of digital pain monitoring tools, advancements in minimally invasive spine technologies, and the broadening of rehabilitation programs. Prominent trends within the forecast timeframe encompass the rising utilization of multimodal pain management, the expansion of interventional spine procedures, an elevated demand for non-opioid therapies, the growth of rehabilitation-based care, and the adoption of minimally invasive pain treatments.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=12795152&type=smp&name=Lumbosacral%20Radicular%20Pain%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Lumbosacral Radicular Pain Market Growth Momentum: What Factors Are Shaping Demand?

The growing occurrence of degenerative spinal conditions is anticipated to drive expansion in the lumbosacral radicular pain market. These conditions encompass various disorders resulting from the progressive deterioration of the spine over time. The increase in degenerative spinal conditions stems from an aging global population and lifestyle choices that heighten the likelihood of spinal degradation and nerve compression, consequently boosting the need for diagnostic and therapeutic interventions. Lumbosacral radicular pain serves as an indicator of underlying degenerative spinal issues by signaling irritation or compression of nerve roots, thereby guiding clinical assessments and treatment strategies. For example, the University of Sydney, an Australian public university, reported in May 2023 an expectation that over 800 million individuals globally will experience back discomfort by the year 2050. This surge in degenerative spinal conditions is, therefore, a key factor propelling the growth of the lumbosacral radicular pain market.

Lumbosacral Radicular Pain Market Segmentation And Category Overview

The lumbosacral radicular pain market covered in this report is segmented –

1) By Treatment Type: Pharmacological Treatment, Non-Pharmacological Treatment, Interventional Procedures

2) By Route Of Administration: Oral, Topical, Injectable, Implantable

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By End User: Hospitals, Specialty Clinics, Rehabilitation Centers, Homecare Settings

Subsegments:

1) By Pharmacological Treatment: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Anticonvulsants, Antidepressants, Muscle Relaxants, Corticosteroids

2) By Non-Pharmacological Treatment: Physical Therapy, Exercise And Rehabilitation Programs, Chiropractic Care, Acupuncture, Cognitive Behavioral Therapy, Heat And Cold Therapy

3) By Interventional Procedures: Epidural Steroid Injections, Radiofrequency Ablation, Nerve Root Blocks, Spinal Cord Stimulation, Minimally Invasive Decompression, Intrathecal Drug Delivery Systems

Lumbosacral Radicular Pain Market Competitive Analysis Of Leading Industry Participants

Major companies operating in the lumbosacral radicular pain market are Medtronic plc, Boston Scientific Corporation, Nevro Corp., SPR Therapeutics, Saluda Medical Pty Ltd., Nalu Medical Inc., Abbott Neuromodulation, Stryker Corporation, Zimmer Biomet Holdings Inc., Globus Medical Inc., NuVasive Inc., Orthofix Medical Inc., B. Braun Melsungen AG, Teleflex Incorporated, Merit Medical Systems Inc., Avanos Medical Inc., Halyard Health Inc., Terumo Corporation, Baxter International Inc., Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Pfizer CentreOne, Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Lupin Limited, Zydus Lifesciences Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals Inc., Perrigo Company plc

View The Full Lumbosacral Radicular Pain Market Report:

https://thebusinessresearchcompany.com/report/lumbosacral-radicular-pain-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Lumbosacral Radicular Pain Market Geographic Landscape: Which Region Leads Industry Growth?

North America was the largest region in the lumbosacral radicular pain market in 2025. The regions covered in the lumbosacral radicular pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Lumbosacral Radicular Pain Market Size, Value And Growth Trajectory Through 2030

The lumbosacral radicular pain market has witnessed strong expansion in recent years. It is projected to increase from $0.97 billion in 2025 to $1.02 billion in 2026, registering a compound annual growth rate (CAGR) of 6.0%. The historical growth of this market can be linked to elements like an aging population, the prevalence of spinal degenerative disorders, the approach of opioid-based pain management, the establishment of hospital pain clinics, and the rising volumes of orthopedic surgeries.

The lumbosacral radicular pain market size is anticipated to undergo significant growth in the upcoming years. It is projected to achieve a value of $1.28 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.7%. This expansion during the forecast period can be ascribed to elements such as the embrace of non-opioid pain therapy, the increase in outpatient pain procedures, the emergence of digital pain monitoring tools, advancements in minimally invasive spine technologies, and the broadening of rehabilitation programs. Prominent trends within the forecast timeframe encompass the rising utilization of multimodal pain management, the expansion of interventional spine procedures, an elevated demand for non-opioid therapies, the growth of rehabilitation-based care, and the adoption of minimally invasive pain treatments.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=12795152&type=smp&name=Lumbosacral%20Radicular%20Pain%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Lumbosacral Radicular Pain Market Growth Momentum: What Factors Are Shaping Demand?

The growing occurrence of degenerative spinal conditions is anticipated to drive expansion in the lumbosacral radicular pain market. These conditions encompass various disorders resulting from the progressive deterioration of the spine over time. The increase in degenerative spinal conditions stems from an aging global population and lifestyle choices that heighten the likelihood of spinal degradation and nerve compression, consequently boosting the need for diagnostic and therapeutic interventions. Lumbosacral radicular pain serves as an indicator of underlying degenerative spinal issues by signaling irritation or compression of nerve roots, thereby guiding clinical assessments and treatment strategies. For example, the University of Sydney, an Australian public university, reported in May 2023 an expectation that over 800 million individuals globally will experience back discomfort by the year 2050. This surge in degenerative spinal conditions is, therefore, a key factor propelling the growth of the lumbosacral radicular pain market.

Lumbosacral Radicular Pain Market Segmentation And Category Overview

The lumbosacral radicular pain market covered in this report is segmented –

1) By Treatment Type: Pharmacological Treatment, Non-Pharmacological Treatment, Interventional Procedures

2) By Route Of Administration: Oral, Topical, Injectable, Implantable

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By End User: Hospitals, Specialty Clinics, Rehabilitation Centers, Homecare Settings

Subsegments:

1) By Pharmacological Treatment: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Anticonvulsants, Antidepressants, Muscle Relaxants, Corticosteroids

2) By Non-Pharmacological Treatment: Physical Therapy, Exercise And Rehabilitation Programs, Chiropractic Care, Acupuncture, Cognitive Behavioral Therapy, Heat And Cold Therapy

3) By Interventional Procedures: Epidural Steroid Injections, Radiofrequency Ablation, Nerve Root Blocks, Spinal Cord Stimulation, Minimally Invasive Decompression, Intrathecal Drug Delivery Systems

Lumbosacral Radicular Pain Market Competitive Analysis Of Leading Industry Participants

Major companies operating in the lumbosacral radicular pain market are Medtronic plc, Boston Scientific Corporation, Nevro Corp., SPR Therapeutics, Saluda Medical Pty Ltd., Nalu Medical Inc., Abbott Neuromodulation, Stryker Corporation, Zimmer Biomet Holdings Inc., Globus Medical Inc., NuVasive Inc., Orthofix Medical Inc., B. Braun Melsungen AG, Teleflex Incorporated, Merit Medical Systems Inc., Avanos Medical Inc., Halyard Health Inc., Terumo Corporation, Baxter International Inc., Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Pfizer CentreOne, Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Lupin Limited, Zydus Lifesciences Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals Inc., Perrigo Company plc

View The Full Lumbosacral Radicular Pain Market Report:

https://thebusinessresearchcompany.com/report/lumbosacral-radicular-pain-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Lumbosacral Radicular Pain Market Geographic Landscape: Which Region Leads Industry Growth?

North America was the largest region in the lumbosacral radicular pain market in 2025. The regions covered in the lumbosacral radicular pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Lumbosacral Radicular Pain Market Expansion Outlook: What Revenue Opportunities Lie Ahead?

In recent years, the market for lumbosacral radicular pain has experienced robust expansion. Projected to rise from $0.97 billion in 2025 to $1.02 billion in 2026, this growth reflects a compound annual growth rate (CAGR) of 6.0%. Historical progress has been driven by factors such as an aging demographic, spinal degenerative conditions, use of opioids for pain control, hospital-based pain management clinics, and the volume of orthopedic surgical procedures.

Projections indicate that the lumbosacral radicular pain market will experience robust expansion in the coming years, reaching $1.28 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.7%. This anticipated growth during the forecast period is fueled by the increasing uptake of non-opioid pain therapies, a rise in outpatient pain management procedures, the integration of digital tools for pain monitoring, advancements in minimally invasive spine technologies, and the broadening of rehabilitation programs. Key trends shaping this period include a greater emphasis on multimodal pain management approaches, a surge in interventional spine procedures, heightened demand for treatments that avoid opioids, an expansion of rehabilitation-focused care models, and a growing preference for minimally invasive interventions to address pain.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24591&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Lumbosacral Radicular Pain Market Demand Drivers Creating New Revenue Opportunities

The increasing prevalence of degenerative spinal conditions is expected to propel the growth of the lumbosacral radicular pain market going forward. Degenerative spinal conditions refer to a group of disorders caused by the gradual wear and tear of the spine over time. The rise in degenerative spinal conditions is due to aging populations and lifestyle factors that increase the risk of spinal wear and nerve compression, leading to higher demand for diagnosis and treatment. Lumbosacral radicular pain helps identify underlying degenerative spinal conditions by signaling nerve root irritation or compression, guiding clinical evaluation and management. For instance, in May 2023, according to the University of Sydney, an Australia-based public university, it is anticipated that more than 800 million people worldwide will suffer from back discomfort by 2050. Therefore, the increasing prevalence of degenerative spinal conditions drives the growth of the lumbosacral radicular pain market.

Lumbosacral Radicular Pain Market Driver: Rising Prevalence Of Obesity Driving The Market Growth Due To Sedentary Lifestyles And Dietary Changes

The rising prevalence of obesity is expected to propel the growth of the lumbosacral radicular pain market going forward. Obesity refers to a medical condition characterized by excessive body fat accumulation, typically defined as having a body mass index of 30 or higher, which increases the risk of various health complications. The increasing prevalence of obesity is driven by sedentary lifestyles and processed food consumption patterns, as modern work environments increasingly involve prolonged sitting and desk-based activities while convenient access to high-calorie, nutrient-poor foods has become widespread in developed nations. Growing obesity directly supports higher incidence of lower back and leg pain caused by compressed nerve roots, as excess body weight places additional mechanical stress on the lumbar spine and surrounding structures, leading to nerve compression and inflammation. For instance, in May 2025, according to the Office for Health Improvement and Disparities, a UK-based government body, from 2023 to 2024, an estimated 64.5% of adults aged 18 and over in England were overweight or living with obesity, up from 64.0% in 2022 to 2023. Therefore, the rising prevalence of obesity is driving the growth of the lumbosacral radicular pain market.

Lumbosacral Radicular Pain Market Segment Analysis And Revenue Opportunities

The lumbosacral radicular pain market covered in this report is segmented –

1) By Treatment Type: Pharmacological Treatment, Non-Pharmacological Treatment, Interventional Procedures

2) By Route Of Administration: Oral, Topical, Injectable, Implantable

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By End User: Hospitals, Specialty Clinics, Rehabilitation Centers, Homecare Settings

Subsegments:

1) By Pharmacological Treatment: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Anticonvulsants, Antidepressants, Muscle Relaxants, Corticosteroids

2) By Non-Pharmacological Treatment: Physical Therapy, Exercise And Rehabilitation Programs, Chiropractic Care, Acupuncture, Cognitive Behavioral Therapy, Heat And Cold Therapy

3) By Interventional Procedures: Epidural Steroid Injections, Radiofrequency Ablation, Nerve Root Blocks, Spinal Cord Stimulation, Minimally Invasive Decompression, Intrathecal Drug Delivery Systems

Lumbosacral Radicular Pain Market Leading Players Shaping Industry Direction

Major companies operating in the lumbosacral radicular pain market are Medtronic plc, Boston Scientific Corporation, Nevro Corp., SPR Therapeutics, Saluda Medical Pty Ltd., Nalu Medical Inc., Abbott Neuromodulation, Stryker Corporation, Zimmer Biomet Holdings Inc., Globus Medical Inc., NuVasive Inc., Orthofix Medical Inc., B. Braun Melsungen AG, Teleflex Incorporated, Merit Medical Systems Inc., Avanos Medical Inc., Halyard Health Inc., Terumo Corporation, Baxter International Inc., Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Pfizer CentreOne, Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Lupin Limited, Zydus Lifesciences Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals Inc., Perrigo Company plc

Access The Complete Lumbosacral Radicular Pain Market Report:

https://www.thebusinessresearchcompany.com/report/lumbosacral-radicular-pain-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Lumbosacral Radicular Pain Market Geographic Distribution And Regional Opportunities

North America was the largest region in the lumbosacral radicular pain market in 2025. The regions covered in the lumbosacral radicular pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Size Of The Lumbosacral Radicular Pain Market In 2026 And How Much Will It Reach By 2030?

The lumbosacral radicular pain market size has demonstrated robust growth in recent years. It is projected to expand from $0.97 billion in 2025 to $1.02 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.0%. This market’s historical growth can be linked to factors such as an aging population, spinal degenerative disorders, opioid-based pain management, the presence of hospital pain clinics, and the volume of orthopedic surgery procedures.

The lumbosacral radicular pain market size is projected to experience robust expansion in the coming years. It is set to reach $1.28 billion in 2030, showing a compound annual growth rate (CAGR) of 5.7%. The anticipated growth within the forecast period can be attributed to factors such as the adoption of non-opioid pain therapies, an increase in outpatient pain procedures, the availability of digital pain monitoring tools, advancements in minimally invasive spine technologies, and the expansion of rehabilitation programs. Major trends influencing this period include the rising utilization of multimodal pain management strategies, the growth of interventional spine procedures, an increased demand for non-opioid therapies, the broadening of rehabilitation-based care, and the integration of minimally invasive pain treatments.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24591&type=smp

Which Strategic Drivers Are Supporting The Lumbosacral Radicular Pain Market Development?

The growing occurrence of degenerative spinal conditions is projected to boost the lumbosacral radicular pain market’s expansion in the future. These conditions encompass various disorders resulting from the progressive deterioration of the spine over time. This increase stems from demographic shifts towards older populations and lifestyle choices that elevate the likelihood of spinal degradation and nerve impingement, consequently driving up the need for diagnostic and therapeutic interventions. Lumbosacral radicular pain serves as an indicator for underlying degenerative spinal issues by signaling nerve root irritation or compression, thereby informing clinical assessment and patient care. As an illustration, the University of Sydney, an Australia-based public university, reported in May 2023 that global back discomfort is expected to affect over 800 million individuals by 2050. Consequently, the rising incidence of degenerative spinal conditions is a key driver for the expansion of the lumbosacral radicular pain market.

How Is The Lumbosacral Radicular Pain Market Distributed Across Key Segments?

The lumbosacral radicular pain market covered in this report is segmented –

1) By Treatment Type: Pharmacological Treatment, Non-Pharmacological Treatment, Interventional Procedures

2) By Route Of Administration: Oral, Topical, Injectable, Implantable

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By End User: Hospitals, Specialty Clinics, Rehabilitation Centers, Homecare Settings

Subsegments:

1) By Pharmacological Treatment: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Anticonvulsants, Antidepressants, Muscle Relaxants, Corticosteroids

2) By Non-Pharmacological Treatment: Physical Therapy, Exercise And Rehabilitation Programs, Chiropractic Care, Acupuncture, Cognitive Behavioral Therapy, Heat And Cold Therapy

3) By Interventional Procedures: Epidural Steroid Injections, Radiofrequency Ablation, Nerve Root Blocks, Spinal Cord Stimulation, Minimally Invasive Decompression, Intrathecal Drug Delivery Systems

Which Companies Are Engaged In The Lumbosacral Radicular Pain Market Environment?

Major companies operating in the lumbosacral radicular pain market are Medtronic plc, Boston Scientific Corporation, Nevro Corp., SPR Therapeutics, Saluda Medical Pty Ltd., Nalu Medical Inc., Abbott Neuromodulation, Stryker Corporation, Zimmer Biomet Holdings Inc., Globus Medical Inc., NuVasive Inc., Orthofix Medical Inc., B. Braun Melsungen AG, Teleflex Incorporated, Merit Medical Systems Inc., Avanos Medical Inc., Halyard Health Inc., Terumo Corporation, Baxter International Inc., Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Pfizer CentreOne, Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Lupin Limited, Zydus Lifesciences Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals Inc., Perrigo Company plc

Access The Complete Lumbosacral Radicular Pain Market Report:

https://www.thebusinessresearchcompany.com/report/lumbosacral-radicular-pain-global-market-report

Which Region Stands As The Largest Contributor To The Lumbosacral Radicular Pain Market?

North America was the largest region in the lumbosacral radicular pain market in 2025. The regions covered in the lumbosacral radicular pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Lumbosacral Radicular Pain Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24591&type=smp

Browse Through More Reports Similar to the Global Lumbosacral Radicular Pain Market 2026, By The Business Research Company

Joint Pain Injections Market Report 2026

https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report

Neuropathic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report

Chronic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Lumbosacral Radicular Pain Market In 2026 And 2030?

The lumbosacral radicular pain market size has experienced significant expansion in recent years. This market is set to increase from $0.97 billion in 2025 to $1.02 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.0%. The strong growth observed in the past can be ascribed to elements such as an aging population, the occurrence of spinal degenerative disorders, the use of opioid-based pain management, the presence of hospital pain clinics, and the volume of orthopedic surgery procedures.

The lumbosacral radicular pain market size is projected for substantial expansion over the next few years. It is forecast to reach $1.28 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.7%. This anticipated growth can be linked to the increased adoption of non-opioid pain therapies, the prevalence of outpatient pain procedures, the use of digital pain monitoring tools, advances in minimally invasive spine technologies, and the extension of rehabilitation programs. Prominent trends throughout the forecast period encompass a rising application of multimodal pain management, an increase in interventional spine procedures, a greater need for non-opioid therapies, the broadening of rehabilitation-based care, and the utilization of minimally invasive pain treatments.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24591&type=smp

What Key Factors Are Affecting The Lumbosacral Radicular Pain Market Demand?

The increasing incidence of degenerative spinal conditions is anticipated to fuel the expansion of the lumbosacral radicular pain market moving forward. These conditions describe a collection of ailments resulting from the progressive deterioration of the spine over time. The surge in degenerative spinal conditions arises from aging populations and lifestyle elements that heighten the likelihood of spinal wear and nerve compression, thereby increasing the necessity for diagnosis and treatment. Lumbosacral radicular pain plays a role in pinpointing underlying degenerative spinal issues by signaling nerve root irritation or compression, which aids in clinical assessment and management. For instance, in May 2023, as per the University of Sydney, an Australia-based public university, it is projected that over 800 million people globally will experience back discomfort by 2050. Hence, the rising prevalence of degenerative spinal conditions is a primary factor driving the growth of the lumbosacral radicular pain market.

How Is The Lumbosacral Radicular Pain Market Categorized Across Its Segment Groups?

The lumbosacral radicular pain market covered in this report is segmented –

1) By Treatment Type: Pharmacological Treatment, Non-Pharmacological Treatment, Interventional Procedures

2) By Route Of Administration: Oral, Topical, Injectable, Implantable

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By End User: Hospitals, Specialty Clinics, Rehabilitation Centers, Homecare Settings

Subsegments:

1) By Pharmacological Treatment: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Anticonvulsants, Antidepressants, Muscle Relaxants, Corticosteroids

2) By Non-Pharmacological Treatment: Physical Therapy, Exercise And Rehabilitation Programs, Chiropractic Care, Acupuncture, Cognitive Behavioral Therapy, Heat And Cold Therapy

3) By Interventional Procedures: Epidural Steroid Injections, Radiofrequency Ablation, Nerve Root Blocks, Spinal Cord Stimulation, Minimally Invasive Decompression, Intrathecal Drug Delivery Systems

Which Firms Are Influencing Competition In The Lumbosacral Radicular Pain Market?

Major companies operating in the lumbosacral radicular pain market are Medtronic plc, Boston Scientific Corporation, Nevro Corp., SPR Therapeutics, Saluda Medical Pty Ltd., Nalu Medical Inc., Abbott Neuromodulation, Stryker Corporation, Zimmer Biomet Holdings Inc., Globus Medical Inc., NuVasive Inc., Orthofix Medical Inc., B. Braun Melsungen AG, Teleflex Incorporated, Merit Medical Systems Inc., Avanos Medical Inc., Halyard Health Inc., Terumo Corporation, Baxter International Inc., Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Pfizer CentreOne, Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Lupin Limited, Zydus Lifesciences Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals Inc., Perrigo Company plc

Get The Full Lumbosacral Radicular Pain Market Report:

https://www.thebusinessresearchcompany.com/report/lumbosacral-radicular-pain-global-market-report

Where Is The Lumbosacral Radicular Pain Market Primarily Concentrated By Region?

North America was the largest region in the lumbosacral radicular pain market in 2025. The regions covered in the lumbosacral radicular pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Lumbosacral Radicular Pain Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/lumbosacral-radicular-pain-global-market-report

Browse Through More Reports Similar to the Global Lumbosacral Radicular Pain Market 2026, By The Business Research Company

Joint Pain Injections Market Report 2026

https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report

Neuropathic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report

Chronic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Lumbosacral Radicular Pain Market Over The 2026–2030 Period?

The lumbosacral radicular pain market has experienced significant growth in recent years. It is anticipated to expand from $0.97 billion in 2025 to $1.02 billion in 2026, at a compound annual growth rate (CAGR) of 6.0%. The historical increase can be attributed to factors such as an aging population, the prevalence of spinal degenerative disorders, the methods used for opioid-based pain management, the role of hospital pain clinics, and the quantity of orthopedic surgery procedures.

The lumbosacral radicular pain market is poised for significant expansion over the coming years. It is projected to reach $1.28 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.7%. This anticipated growth during the forecast period stems from the increasing adoption of non-opioid pain therapy, a rise in outpatient pain procedures, the utilization of digital pain monitoring tools, advancements in minimally invasive spine technologies, and the expansion of rehabilitation programs. Prominent trends throughout this period include a greater emphasis on multimodal pain management, an increase in interventional spine procedures, a heightened call for non-opioid therapies, the enlargement of rehabilitation-based care, and the widespread use of minimally invasive pain treatments.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24591&type=smp

What Drivers Are Expected To Influence The Lumbosacral Radicular Pain Market During The Forecast Period?

The growing occurrence of degenerative spinal conditions is projected to boost the expansion of the lumbosacral radicular pain market. These conditions encompass ailments resulting from the progressive deterioration of the spine over a period. An increase in such conditions stems from an aging global populace and lifestyle choices that heighten spinal degeneration and nerve compression risks, thereby increasing the need for diagnostic and therapeutic services. This specific pain indicates irritation or compression of nerve roots, thereby aiding in the identification of underlying degenerative spinal issues and informing clinical assessment and care. For example, the University of Sydney, an Australian public university, reported in May 2023 that global back discomfort is expected to affect over 800 million people worldwide by 2050. Consequently, the increasing prevalence of degenerative spinal conditions acts as a significant catalyst for the growth of the lumbosacral radicular pain market.

How Is The Lumbosacral Radicular Pain Market Segmented Across Key Categories?

The lumbosacral radicular pain market covered in this report is segmented –

1) By Treatment Type: Pharmacological Treatment, Non-Pharmacological Treatment, Interventional Procedures

2) By Route Of Administration: Oral, Topical, Injectable, Implantable

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By End User: Hospitals, Specialty Clinics, Rehabilitation Centers, Homecare Settings

Subsegments:

1) By Pharmacological Treatment: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Anticonvulsants, Antidepressants, Muscle Relaxants, Corticosteroids

2) By Non-Pharmacological Treatment: Physical Therapy, Exercise And Rehabilitation Programs, Chiropractic Care, Acupuncture, Cognitive Behavioral Therapy, Heat And Cold Therapy

3) By Interventional Procedures: Epidural Steroid Injections, Radiofrequency Ablation, Nerve Root Blocks, Spinal Cord Stimulation, Minimally Invasive Decompression, Intrathecal Drug Delivery Systems

Who Are The Dominant Players Shaping The Lumbosacral Radicular Pain Market Landscape?

Major companies operating in the lumbosacral radicular pain market are Medtronic plc, Boston Scientific Corporation, Nevro Corp., SPR Therapeutics, Saluda Medical Pty Ltd., Nalu Medical Inc., Abbott Neuromodulation, Stryker Corporation, Zimmer Biomet Holdings Inc., Globus Medical Inc., NuVasive Inc., Orthofix Medical Inc., B. Braun Melsungen AG, Teleflex Incorporated, Merit Medical Systems Inc., Avanos Medical Inc., Halyard Health Inc., Terumo Corporation, Baxter International Inc., Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Pfizer CentreOne, Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Lupin Limited, Zydus Lifesciences Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals Inc., Perrigo Company plc

Read the full lumbosacral radicular pain market report here:

https://www.thebusinessresearchcompany.com/report/lumbosacral-radicular-pain-global-market-report

Which Region Is Forecast To Lead The Lumbosacral Radicular Pain Market In Terms Of Market Size?

North America was the largest region in the lumbosacral radicular pain market in 2025. The regions covered in the lumbosacral radicular pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Lumbosacral Radicular Pain Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24591&type=smp

Browse Through More Reports Similar to the Global Lumbosacral Radicular Pain Market 2026, By The Business Research Company

Joint Pain Injections Market Report 2026

https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report

Neuropathic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report

Chronic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Lumbosacral Radicular Pain Market Over The 2026–2030 Period?

The lumbosacral radicular pain market has experienced significant growth in recent years. It is anticipated to expand from $0.97 billion in 2025 to $1.02 billion in 2026, at a compound annual growth rate (CAGR) of 6.0%. The historical increase can be attributed to factors such as an aging population, the prevalence of spinal degenerative disorders, the methods used for opioid-based pain management, the role of hospital pain clinics, and the quantity of orthopedic surgery procedures.

The lumbosacral radicular pain market is poised for significant expansion over the coming years. It is projected to reach $1.28 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.7%. This anticipated growth during the forecast period stems from the increasing adoption of non-opioid pain therapy, a rise in outpatient pain procedures, the utilization of digital pain monitoring tools, advancements in minimally invasive spine technologies, and the expansion of rehabilitation programs. Prominent trends throughout this period include a greater emphasis on multimodal pain management, an increase in interventional spine procedures, a heightened call for non-opioid therapies, the enlargement of rehabilitation-based care, and the widespread use of minimally invasive pain treatments.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24591&type=smp

What Drivers Are Expected To Influence The Lumbosacral Radicular Pain Market During The Forecast Period?

The growing occurrence of degenerative spinal conditions is projected to boost the expansion of the lumbosacral radicular pain market. These conditions encompass ailments resulting from the progressive deterioration of the spine over a period. An increase in such conditions stems from an aging global populace and lifestyle choices that heighten spinal degeneration and nerve compression risks, thereby increasing the need for diagnostic and therapeutic services. This specific pain indicates irritation or compression of nerve roots, thereby aiding in the identification of underlying degenerative spinal issues and informing clinical assessment and care. For example, the University of Sydney, an Australian public university, reported in May 2023 that global back discomfort is expected to affect over 800 million people worldwide by 2050. Consequently, the increasing prevalence of degenerative spinal conditions acts as a significant catalyst for the growth of the lumbosacral radicular pain market.

How Is The Lumbosacral Radicular Pain Market Segmented Across Key Categories?

The lumbosacral radicular pain market covered in this report is segmented –

1) By Treatment Type: Pharmacological Treatment, Non-Pharmacological Treatment, Interventional Procedures

2) By Route Of Administration: Oral, Topical, Injectable, Implantable

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By End User: Hospitals, Specialty Clinics, Rehabilitation Centers, Homecare Settings

Subsegments:

1) By Pharmacological Treatment: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Anticonvulsants, Antidepressants, Muscle Relaxants, Corticosteroids

2) By Non-Pharmacological Treatment: Physical Therapy, Exercise And Rehabilitation Programs, Chiropractic Care, Acupuncture, Cognitive Behavioral Therapy, Heat And Cold Therapy

3) By Interventional Procedures: Epidural Steroid Injections, Radiofrequency Ablation, Nerve Root Blocks, Spinal Cord Stimulation, Minimally Invasive Decompression, Intrathecal Drug Delivery Systems

Who Are The Dominant Players Shaping The Lumbosacral Radicular Pain Market Landscape?

Major companies operating in the lumbosacral radicular pain market are Medtronic plc, Boston Scientific Corporation, Nevro Corp., SPR Therapeutics, Saluda Medical Pty Ltd., Nalu Medical Inc., Abbott Neuromodulation, Stryker Corporation, Zimmer Biomet Holdings Inc., Globus Medical Inc., NuVasive Inc., Orthofix Medical Inc., B. Braun Melsungen AG, Teleflex Incorporated, Merit Medical Systems Inc., Avanos Medical Inc., Halyard Health Inc., Terumo Corporation, Baxter International Inc., Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Pfizer CentreOne, Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Lupin Limited, Zydus Lifesciences Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals Inc., Perrigo Company plc

Read the full lumbosacral radicular pain market report here:

https://www.thebusinessresearchcompany.com/report/lumbosacral-radicular-pain-global-market-report

Which Region Is Forecast To Lead The Lumbosacral Radicular Pain Market In Terms Of Market Size?

North America was the largest region in the lumbosacral radicular pain market in 2025. The regions covered in the lumbosacral radicular pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Lumbosacral Radicular Pain Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24591&type=smp

Browse Through More Reports Similar to the Global Lumbosacral Radicular Pain Market 2026, By The Business Research Company

Joint Pain Injections Market Report 2026

https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report

Neuropathic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report

Chronic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Lumbosacral Radicular Pain Market Over The 2026–2030 Period?

The lumbosacral radicular pain market has experienced significant growth in recent years. It is anticipated to expand from $0.97 billion in 2025 to $1.02 billion in 2026, at a compound annual growth rate (CAGR) of 6.0%. The historical increase can be attributed to factors such as an aging population, the prevalence of spinal degenerative disorders, the methods used for opioid-based pain management, the role of hospital pain clinics, and the quantity of orthopedic surgery procedures.

The lumbosacral radicular pain market is poised for significant expansion over the coming years. It is projected to reach $1.28 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.7%. This anticipated growth during the forecast period stems from the increasing adoption of non-opioid pain therapy, a rise in outpatient pain procedures, the utilization of digital pain monitoring tools, advancements in minimally invasive spine technologies, and the expansion of rehabilitation programs. Prominent trends throughout this period include a greater emphasis on multimodal pain management, an increase in interventional spine procedures, a heightened call for non-opioid therapies, the enlargement of rehabilitation-based care, and the widespread use of minimally invasive pain treatments.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24591&type=smp

What Drivers Are Expected To Influence The Lumbosacral Radicular Pain Market During The Forecast Period?

The growing occurrence of degenerative spinal conditions is projected to boost the expansion of the lumbosacral radicular pain market. These conditions encompass ailments resulting from the progressive deterioration of the spine over a period. An increase in such conditions stems from an aging global populace and lifestyle choices that heighten spinal degeneration and nerve compression risks, thereby increasing the need for diagnostic and therapeutic services. This specific pain indicates irritation or compression of nerve roots, thereby aiding in the identification of underlying degenerative spinal issues and informing clinical assessment and care. For example, the University of Sydney, an Australian public university, reported in May 2023 that global back discomfort is expected to affect over 800 million people worldwide by 2050. Consequently, the increasing prevalence of degenerative spinal conditions acts as a significant catalyst for the growth of the lumbosacral radicular pain market.

How Is The Lumbosacral Radicular Pain Market Segmented Across Key Categories?

The lumbosacral radicular pain market covered in this report is segmented –

1) By Treatment Type: Pharmacological Treatment, Non-Pharmacological Treatment, Interventional Procedures

2) By Route Of Administration: Oral, Topical, Injectable, Implantable

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By End User: Hospitals, Specialty Clinics, Rehabilitation Centers, Homecare Settings

Subsegments:

1) By Pharmacological Treatment: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Anticonvulsants, Antidepressants, Muscle Relaxants, Corticosteroids

2) By Non-Pharmacological Treatment: Physical Therapy, Exercise And Rehabilitation Programs, Chiropractic Care, Acupuncture, Cognitive Behavioral Therapy, Heat And Cold Therapy

3) By Interventional Procedures: Epidural Steroid Injections, Radiofrequency Ablation, Nerve Root Blocks, Spinal Cord Stimulation, Minimally Invasive Decompression, Intrathecal Drug Delivery Systems

Who Are The Dominant Players Shaping The Lumbosacral Radicular Pain Market Landscape?

Major companies operating in the lumbosacral radicular pain market are Medtronic plc, Boston Scientific Corporation, Nevro Corp., SPR Therapeutics, Saluda Medical Pty Ltd., Nalu Medical Inc., Abbott Neuromodulation, Stryker Corporation, Zimmer Biomet Holdings Inc., Globus Medical Inc., NuVasive Inc., Orthofix Medical Inc., B. Braun Melsungen AG, Teleflex Incorporated, Merit Medical Systems Inc., Avanos Medical Inc., Halyard Health Inc., Terumo Corporation, Baxter International Inc., Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Pfizer CentreOne, Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Lupin Limited, Zydus Lifesciences Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals Inc., Perrigo Company plc

Read the full lumbosacral radicular pain market report here:

https://www.thebusinessresearchcompany.com/report/lumbosacral-radicular-pain-global-market-report

Which Region Is Forecast To Lead The Lumbosacral Radicular Pain Market In Terms Of Market Size?

North America was the largest region in the lumbosacral radicular pain market in 2025. The regions covered in the lumbosacral radicular pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Lumbosacral Radicular Pain Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24591&type=smp

Browse Through More Reports Similar to the Global Lumbosacral Radicular Pain Market 2026, By The Business Research Company

Joint Pain Injections Market Report 2026

https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report

Neuropathic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report

Chronic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the lumbosacral radicular pain market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Lumbosacral Radicular Pain Market expected to reach by 2030?

The lumbosacral radicular pain market has experienced significant expansion in recent years. It is projected to grow from $0.97 billion in 2025 to $1.02 billion in 2026, at a compound annual growth rate (CAGR) of 6.0%. This historical market development can be ascribed to elements such as an aging population, the prevalence of spinal degenerative disorders, practices in opioid-based pain management, the establishment of hospital pain clinics, and the volumes of orthopedic surgery conducted.

The lumbosacral radicular pain market is projected to experience robust expansion over the coming years. By 2030, its valuation is anticipated to reach $1.28 billion, progressing at a compound annual growth rate (CAGR) of 5.7%. This anticipated growth during the forecast timeframe is attributable to factors such as the embrace of non-opioid pain therapies, an increase in outpatient pain procedures, the integration of digital pain monitoring tools, advancements in minimally invasive spine technologies, and the broadening of rehabilitation programs. Key trends shaping the forecast period encompass a surge in multimodal pain management approaches, the expansion of interventional spine procedures, a heightened demand for non-opioid treatments, the widening scope of rehabilitation-focused care, and the uptake of minimally invasive pain solutions.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24591&type=smp

What Drivers Are Driving Adoption Within The Lumbosacral Radicular Pain Market?

The growing occurrence of degenerative spinal conditions is projected to boost the lumbosacral radicular pain market in the future. These conditions are characterized by the spine’s gradual deterioration over time. The increase in degenerative spinal conditions stems from aging demographics and lifestyle choices that heighten the risk of spinal wear and nerve impingement, consequently elevating the need for diagnosis and therapeutic interventions. Lumbosacral radicular pain serves as an indicator for underlying degenerative spinal issues by signaling nerve root irritation or compression, thereby guiding clinical assessment and treatment strategies. For instance, in May 2023, the University of Sydney, an Australia-based public university, predicted that more than 800 million individuals globally will experience back discomfort by 2050. Consequently, the rising incidence of degenerative spinal conditions is a key driver for the expansion of the lumbosacral radicular pain market. The escalating rate of obesity is anticipated to foster the expansion of the lumbosacral radicular pain market in the coming years. Obesity is a medical condition defined by an excessive accumulation of body fat, typically when the body mass index reaches 30 or higher, which elevates the likelihood of various health issues. The surge in obesity is fueled by inactive lifestyles and prevalent consumption of processed foods, as contemporary work environments increasingly entail extended periods of sitting and desk-bound activities, while readily available high-calorie, low-nutrient foods have become widespread in developed nations. Increased obesity directly contributes to a higher occurrence of lower back and leg pain resulting from compressed nerve roots, given that surplus body weight exerts additional mechanical strain on the lumbar spine and adjacent structures, causing nerve compression and inflammation. For instance, in May 2025, according to the Office for Health Improvement and Disparities, a UK-based government body, an estimated 64.5% of adults aged 18 and over in England were classified as overweight or living with obesity from 2023 to 2024, an increase from 64.0% in 2022 to 2023. Consequently, the rising prevalence of obesity is a significant factor propelling the growth of the lumbosacral radicular pain market.

What Segments Are Included Within The Lumbosacral Radicular Pain Market?

The lumbosacral radicular pain market covered in this report is segmented –

1) By Treatment Type: Pharmacological Treatment, Non-Pharmacological Treatment, Interventional Procedures

2) By Route Of Administration: Oral, Topical, Injectable, Implantable

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By End User: Hospitals, Specialty Clinics, Rehabilitation Centers, Homecare Settings

Subsegments:

1) By Pharmacological Treatment: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Anticonvulsants, Antidepressants, Muscle Relaxants, Corticosteroids

2) By Non-Pharmacological Treatment: Physical Therapy, Exercise And Rehabilitation Programs, Chiropractic Care, Acupuncture, Cognitive Behavioral Therapy, Heat And Cold Therapy

3) By Interventional Procedures: Epidural Steroid Injections, Radiofrequency Ablation, Nerve Root Blocks, Spinal Cord Stimulation, Minimally Invasive Decompression, Intrathecal Drug Delivery Systems

Who Are The Top-Performing Companies In The Lumbosacral Radicular Pain Market In Recent Years?

Major companies operating in the lumbosacral radicular pain market are Medtronic plc, Boston Scientific Corporation, Nevro Corp., SPR Therapeutics, Saluda Medical Pty Ltd., Nalu Medical Inc., Abbott Neuromodulation, Stryker Corporation, Zimmer Biomet Holdings Inc., Globus Medical Inc., NuVasive Inc., Orthofix Medical Inc., B. Braun Melsungen AG, Teleflex Incorporated, Merit Medical Systems Inc., Avanos Medical Inc., Halyard Health Inc., Terumo Corporation, Baxter International Inc., Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Pfizer CentreOne, Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Lupin Limited, Zydus Lifesciences Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals Inc., Perrigo Company plc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/lumbosacral-radicular-pain-global-market-report

Which Region Currently Holds The Largest Share Of The Lumbosacral Radicular Pain Market?

North America was the largest region in the lumbosacral radicular pain market in 2025. The regions covered in the lumbosacral radicular pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Lumbosacral Radicular Pain Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24591&type=smp

Browse Through More Reports Similar to the Global Lumbosacral Radicular Pain Market 2026, By The Business Research Company

Joint Pain Injections Market Report 2026

https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report

Neuropathic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report

Chronic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model